This working party has come out of the group’s ICAT (COVID-19 Action Taskforce) workstream work which was looking at the longer term impacts on (re)insurers and the wider market from the changing risk profile of policyholders. The ICAT workstream dug deep into the key personal and commercial lines of business affected by COVID-19 from a pricing perspective, and in addition provide a general framework of considerations for GI pricing actuaries when looking at COVID-19 exposures.
This working party will build on this covering personal lines and commercial lines digging into certain classes of business and looking at impact of outcomes from regulatory changes for pricing e.g. FCA pricing review.
Chair | Amerjit Grewal |
---|---|
Membership | 8 |
Established | 2021 |
Related documents
-
Guidance for Member-Led Research Working Parties
9 November 2017
Contact Details
If you want more information about this research working party please contact the Communities Team.
Events calendar
No results found.